U-Cd (μg/g Cr) | N | Mean of U-Cd | Mean of age (y) | KIM-1 prevalence (%) | ||
---|---|---|---|---|---|---|
Men | 0–0.99 | 3 | 1.0 | 45.0 | 0 | (0.0) |
1–1.99 | 10 | 1.5 | 57.0 | 1 | (10.0) | |
2–2.99 | 13 | 2.8 | 51.0 | 3 | (23.1) | |
3–3.99 | 28 | 3.6 | 49.0 | 1 | (3.6) | |
4–4.99 | 26 | 4.5 | 51.5 | 3 | (11.5) | |
5–5.99 | 36 | 5.5 | 56.0 | 8 | (22.2) | |
6–6.99 | 34 | 6.5 | 53.0 | 7 | (20.6) | |
7–7.99 | 20 | 7.5 | 49.0 | 4 | (20.0) | |
8–8.99 | 14 | 8.4 | 58.0 | 3 | (21.4) | |
9–9.99 | 14 | 9.5 | 60.0 | 7 | (50.0) | |
10–14.99 | 47 | 11.8 | 61.0 | 19 | (40.4) | |
15–19.99 | 7 | 15.6 | 47.0 | 0 | (0.0) | |
20 – | 8 | 28.4 | 56.0 | 4 | (50.0) | |
Women | 0–0.99 | 3 | 0.8 | 43.0 | 0 | (0.0) |
1–1.99 | 20 | 1.6 | 52.0 | 1 | (5.0) | |
2–2.99 | 16 | 2.5 | 58.5 | 2 | (12.5) | |
3–3.99 | 44 | 3.5 | 50.5 | 2 | (4.5) | |
4–4.99 | 35 | 4.6 | 53.0 | 4 | (11.4) | |
5–5.99 | 41 | 5.5 | 51.0 | 3 | (7.3) | |
6–6.99 | 43 | 6.6 | 50.0 | 8 | (18.6) | |
7–7.99 | 40 | 7.3 | 53.0 | 5 | (12.5) | |
8–8.99 | 42 | 8.5 | 56.0 | 7 | (16.7) | |
9–9.99 | 35 | 9.4 | 54.0 | 3 | (8.6) | |
10–14.99 | 77 | 11.7 | 54.0 | 11 | (14.3) | |
15–19.99 | 23 | 16.5 | 52.0 | 7 | (30.4) | |
20 – | 21 | 23.9 | 55.0 | 9 | (42.9) |